Double Point Ventures
Boston, Massachusetts, United StatesFounded 2023
Double Point Ventures focuses on catalyzing breakthroughs and transforming medicine by investing in visionary healthcare companies. Their strategy involves backing pioneering innovations in therapeutics, early-revenue diagnostics and devices, and digital health/healthcare services, while providing strategic partnership and long-term commitment to accelerate growth.
67% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $58.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$1.4B
Top Stage
Series D
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Umoja Biopharma | Series C | $100M | Jan 2025 |
 GEMMABio | Seed | $34M | Dec 2024 |
 Neko Health | Series D | $41M | Jun 2024 |
Top Co-Investors
Highland Capital Partners1 shared
NTTVC1 shared
EDBI1 shared
LG1 shared
Earlybird Venture Capital1 shared
DCVC1 shared
ARK Invest1 shared
Cormorant Asset Management1 shared
MPM Capital1 shared
Qiming Venture Partners USA1 shared
RTW Investments1 shared
Alexandria Venture Investments1 shared
SoftBank Vision Fund1 shared
CaaS Capital1 shared
K2 HealthVentures1 shared
Last updated: 15 April 2026